Source Name	Characteristics[organism]	Characteristics[organism part]	Characteristics[age]	Characteristics[developmental stage]	Characteristics[sex]	Characteristics[ancestry category]	Characteristics[disease]	Characteristics[phenotype]	Characteristics[cell type]	Characteristics[cell line]	Characteristics[enrichment process]	Characteristics[biological replicate]	Material Type	assay name	Technology Type	comment[fractionation method]	comment[fraction identifier]	comment[label]	comment[instrument]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[dissociation method]	comment[cleavage agent details]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[file uri]	comment[data file]	Factor Value[compound]	Factor Value[enrichment process]
Sample 1	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 1	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep4_Fr1.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep4_Fr1.raw	none	enrichment of phosphorylated Protein
Sample 1	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 2	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep4_Fr2.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep4_Fr2.raw	none	enrichment of phosphorylated Protein
Sample 1	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 3	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep4_Fr3.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep4_Fr3.raw	none	enrichment of phosphorylated Protein
Sample 1	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 4	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep4_Fr4.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep4_Fr4.raw	none	enrichment of phosphorylated Protein
Sample 1	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 5	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep4_Fr5.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep4_Fr5.raw	none	enrichment of phosphorylated Protein
Sample 1	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 6	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep4_Fr6.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep4_Fr6.raw	none	enrichment of phosphorylated Protein
Sample 2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	5	cell	run 7	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep5_Fr1.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep5_Fr1.raw	none	enrichment of phosphorylated Protein
Sample 2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	5	cell	run 8	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep5_Fr2.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep5_Fr2.raw	none	enrichment of phosphorylated Protein
Sample 2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	5	cell	run 9	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep5_Fr3.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep5_Fr3.raw	none	enrichment of phosphorylated Protein
Sample 2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	5	cell	run 10	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep5_Fr4.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep5_Fr4.raw	none	enrichment of phosphorylated Protein
Sample 2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	5	cell	run 11	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep5_Fr5.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep5_Fr5.raw	none	enrichment of phosphorylated Protein
Sample 2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	5	cell	run 12	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep5_Fr6.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep5_Fr6.raw	none	enrichment of phosphorylated Protein
Sample 3	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 13	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120126_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep1_Fr1.raw	20120126_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep1_Fr1.raw	none	enrichment of phosphorylated Protein
Sample 3	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 14	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120126_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep1_Fr2.raw	20120126_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep1_Fr2.raw	none	enrichment of phosphorylated Protein
Sample 3	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 15	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120126_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep1_Fr3.raw	20120126_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep1_Fr3.raw	none	enrichment of phosphorylated Protein
Sample 3	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 16	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120126_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep1_Fr4.raw	20120126_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep1_Fr4.raw	none	enrichment of phosphorylated Protein
Sample 3	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 17	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120126_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep1_Fr5.raw	20120126_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep1_Fr5.raw	none	enrichment of phosphorylated Protein
Sample 3	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 18	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120126_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep1_Fr6.raw	20120126_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep1_Fr6.raw	none	enrichment of phosphorylated Protein
Sample 4	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 19	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120127_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep2_Fr1.raw	20120127_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep2_Fr1.raw	none	enrichment of phosphorylated Protein
Sample 4	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 20	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120127_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep2_Fr2.raw	20120127_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep2_Fr2.raw	none	enrichment of phosphorylated Protein
Sample 4	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 21	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120127_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep2_Fr3.raw	20120127_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep2_Fr3.raw	none	enrichment of phosphorylated Protein
Sample 4	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 22	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120127_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep2_Fr4.raw	20120127_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep2_Fr4.raw	none	enrichment of phosphorylated Protein
Sample 4	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 23	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120127_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep2_Fr5.raw	20120127_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep2_Fr5.raw	none	enrichment of phosphorylated Protein
Sample 4	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 24	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120127_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep2_Fr6.raw	20120127_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep2_Fr6.raw	none	enrichment of phosphorylated Protein
Sample 5	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 25	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120128_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep3_Fr1.raw	20120128_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep3_Fr1.raw	none	enrichment of phosphorylated Protein
Sample 5	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 26	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120128_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep3_Fr2.raw	20120128_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep3_Fr2.raw	none	enrichment of phosphorylated Protein
Sample 5	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 27	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120128_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep3_Fr3.raw	20120128_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep3_Fr3.raw	none	enrichment of phosphorylated Protein
Sample 5	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 28	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120128_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep3_Fr4.raw	20120128_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep3_Fr4.raw	none	enrichment of phosphorylated Protein
Sample 5	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 29	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120128_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep3_Fr5.raw	20120128_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep3_Fr5.raw	none	enrichment of phosphorylated Protein
Sample 5	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 30	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120128_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep3_Fr6.raw	20120128_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep3_Fr6.raw	none	enrichment of phosphorylated Protein
Sample 6	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	6	cell	run 31	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120202_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep6_Fr1.raw	20120202_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep6_Fr1.raw	none	enrichment of phosphorylated Protein
Sample 6	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	6	cell	run 32	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120206_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep6_Fr2.raw	20120206_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep6_Fr2.raw	none	enrichment of phosphorylated Protein
Sample 6	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	6	cell	run 33	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120206_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep6_Fr3.raw	20120206_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep6_Fr3.raw	none	enrichment of phosphorylated Protein
Sample 6	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	6	cell	run 34	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120206_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep6_Fr4.raw	20120206_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep6_Fr4.raw	none	enrichment of phosphorylated Protein
Sample 6	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	6	cell	run 35	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120206_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep6_Fr5.raw	20120206_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep6_Fr5.raw	none	enrichment of phosphorylated Protein
Sample 6	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	6	cell	run 36	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120206_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep6_Fr6.raw	20120206_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Control_rep6_Fr6.raw	none	enrichment of phosphorylated Protein
Sample 7	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 37	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120207_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep1_Fr1.raw	20120207_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep1_Fr1.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 7	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 38	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120207_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep1_Fr2.raw	20120207_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep1_Fr2.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 7	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 39	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120207_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep1_Fr3.raw	20120207_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep1_Fr3.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 7	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 40	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120207_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep1_Fr4.raw	20120207_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep1_Fr4.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 7	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 41	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120207_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep1_Fr5.raw	20120207_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep1_Fr5.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 7	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 42	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120207_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep1_Fr6.raw	20120207_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep1_Fr6.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 8	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 43	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120208_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep2_Fr1.raw	20120208_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep2_Fr1.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 8	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 44	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120208_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep2_Fr2.raw	20120208_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep2_Fr2.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 8	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 45	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120208_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep2_Fr3.raw	20120208_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep2_Fr3.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 8	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 46	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120208_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep2_Fr4.raw	20120208_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep2_Fr4.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 8	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 47	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120208_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep2_Fr5.raw	20120208_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep2_Fr5.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 8	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 48	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120208_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep2_Fr6.raw	20120208_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep2_Fr6.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 9	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 49	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120215_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep3_Fr1.raw	20120215_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep3_Fr1.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 9	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 50	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120215_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep3_Fr2.raw	20120215_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep3_Fr2.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 9	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 51	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120215_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep3_Fr3.raw	20120215_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep3_Fr3.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 9	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 52	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120215_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep3_Fr4.raw	20120215_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep3_Fr4.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 9	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 53	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120215_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep3_Fr5.raw	20120215_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep3_Fr5.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 9	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 54	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120215_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep3_Fr6.raw	20120215_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep3_Fr6.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 10	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 55	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120217_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep4_Fr1.raw	20120217_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep4_Fr1.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 10	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 56	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120217_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep4_Fr2.raw	20120217_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep4_Fr2.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 10	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 57	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120217_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep4_Fr3.raw	20120217_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep4_Fr3.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 10	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 58	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120217_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep4_Fr4.raw	20120217_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep4_Fr4.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 10	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 59	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120217_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep4_Fr5.raw	20120217_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep4_Fr5.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 10	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 60	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120217_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep4_Fr6.raw	20120217_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_Nocodazole_rep4_Fr6.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 11	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 61	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120224_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep1_Fr1.raw	20120224_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep1_Fr1.raw	EGF	enrichment of phosphorylated Protein
Sample 11	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 62	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120224_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep1_Fr2.raw	20120224_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep1_Fr2.raw	EGF	enrichment of phosphorylated Protein
Sample 11	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 63	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120224_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep1_Fr3.raw	20120224_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep1_Fr3.raw	EGF	enrichment of phosphorylated Protein
Sample 11	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 64	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120224_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep1_Fr4.raw	20120224_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep1_Fr4.raw	EGF	enrichment of phosphorylated Protein
Sample 11	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 65	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120224_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep1_Fr5.raw	20120224_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep1_Fr5.raw	EGF	enrichment of phosphorylated Protein
Sample 11	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 66	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120224_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep1_Fr6.raw	20120224_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep1_Fr6.raw	EGF	enrichment of phosphorylated Protein
Sample 12	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 67	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep2_Fr1.raw	20120225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep2_Fr1.raw	EGF	enrichment of phosphorylated Protein
Sample 12	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 68	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep2_Fr2.raw	20120225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep2_Fr2.raw	EGF	enrichment of phosphorylated Protein
Sample 12	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 69	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep2_Fr3.raw	20120225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep2_Fr3.raw	EGF	enrichment of phosphorylated Protein
Sample 12	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 70	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep2_Fr4.raw	20120225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep2_Fr4.raw	EGF	enrichment of phosphorylated Protein
Sample 12	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 71	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep2_Fr5.raw	20120225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep2_Fr5.raw	EGF	enrichment of phosphorylated Protein
Sample 12	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 72	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep2_Fr6.raw	20120225_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep2_Fr6.raw	EGF	enrichment of phosphorylated Protein
Sample 13	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 73	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120227_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep3_Fr1.raw	20120227_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep3_Fr1.raw	EGF	enrichment of phosphorylated Protein
Sample 13	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 74	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120227_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep3_Fr2.raw	20120227_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep3_Fr2.raw	EGF	enrichment of phosphorylated Protein
Sample 13	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 75	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120227_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep3_Fr3.raw	20120227_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep3_Fr3.raw	EGF	enrichment of phosphorylated Protein
Sample 13	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 76	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120227_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep3_Fr4.raw	20120227_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep3_Fr4.raw	EGF	enrichment of phosphorylated Protein
Sample 13	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 77	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120227_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep3_Fr5.raw	20120227_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep3_Fr5.raw	EGF	enrichment of phosphorylated Protein
Sample 13	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 78	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120227_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep3_Fr6.raw	20120227_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep3_Fr6.raw	EGF	enrichment of phosphorylated Protein
Sample 14	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 79	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120309_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep4_Fr1.raw	20120309_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep4_Fr1.raw	EGF	enrichment of phosphorylated Protein
Sample 14	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 80	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120309_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep4_Fr2.raw	20120309_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep4_Fr2.raw	EGF	enrichment of phosphorylated Protein
Sample 14	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 81	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120309_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep4_Fr3.raw	20120309_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep4_Fr3.raw	EGF	enrichment of phosphorylated Protein
Sample 14	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 82	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120309_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep4_Fr4.raw	20120309_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep4_Fr4.raw	EGF	enrichment of phosphorylated Protein
Sample 14	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 83	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120309_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep4_Fr5.raw	20120309_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep4_Fr5.raw	EGF	enrichment of phosphorylated Protein
Sample 14	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 84	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120309_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep4_Fr6.raw	20120309_EXQ5_KiSh_SA_LabelFree_HeLa_Phospho_EGF_rep4_Fr6.raw	EGF	enrichment of phosphorylated Protein
Sample 15	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 85	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120323_EXQ5_KiSh_SA_LabelFree_HeLa_pY_pervandate_rep1.raw	20120323_EXQ5_KiSh_SA_LabelFree_HeLa_pY_pervandate_rep1.raw	pervandate	enrichment of phosphorylated Protein
Sample 16	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 86	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120413_EXQ5_KiSh_SA_LabelFree_HeLa_pY_pervandate_rep2.raw	20120413_EXQ5_KiSh_SA_LabelFree_HeLa_pY_pervandate_rep2.raw	pervandate	enrichment of phosphorylated Protein
Sample 17	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 87	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120413_EXQ5_KiSh_SA_LabelFree_HeLa_pY_pervandate_rep3.raw	20120413_EXQ5_KiSh_SA_LabelFree_HeLa_pY_pervandate_rep3.raw	pervandate	enrichment of phosphorylated Protein
Sample 18	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 88	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120413_EXQ5_KiSh_SA_LabelFree_HeLa_pY_pervandate_rep4.raw	20120413_EXQ5_KiSh_SA_LabelFree_HeLa_pY_pervandate_rep4.raw	pervandate	enrichment of phosphorylated Protein
Sample 19	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 89	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120414_EXQ5_KiSh_SA_LabelFree_HeLa_pY_control_rep4.raw	20120414_EXQ5_KiSh_SA_LabelFree_HeLa_pY_control_rep4.raw	none	enrichment of phosphorylated Protein
Sample 20	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	5	cell	run 90	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120414_EXQ5_KiSh_SA_LabelFree_HeLa_pY_control_rep5.raw	20120414_EXQ5_KiSh_SA_LabelFree_HeLa_pY_control_rep5.raw	none	enrichment of phosphorylated Protein
Sample 21	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	6	cell	run 91	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120414_EXQ5_KiSh_SA_LabelFree_HeLa_pY_control_rep6.raw	20120414_EXQ5_KiSh_SA_LabelFree_HeLa_pY_control_rep6.raw	none	enrichment of phosphorylated Protein
Sample 22	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 92	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120415_EXQ5_KiSh_SA_LabelFree_HeLa_pY_EGF5_rep1.raw	20120415_EXQ5_KiSh_SA_LabelFree_HeLa_pY_EGF5_rep1.raw	EGF	enrichment of phosphorylated Protein
Sample 23	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 93	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120415_EXQ5_KiSh_SA_LabelFree_HeLa_pY_EGF5_rep2.raw	20120415_EXQ5_KiSh_SA_LabelFree_HeLa_pY_EGF5_rep2.raw	EGF	enrichment of phosphorylated Protein
Sample 24	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 94	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120415_EXQ5_KiSh_SA_LabelFree_HeLa_pY_EGF5_rep3.raw	20120415_EXQ5_KiSh_SA_LabelFree_HeLa_pY_EGF5_rep3.raw	EGF	enrichment of phosphorylated Protein
Sample 25	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 95	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120415_EXQ5_KiSh_SA_LabelFree_HeLa_pY_EGF5_rep4.raw	20120415_EXQ5_KiSh_SA_LabelFree_HeLa_pY_EGF5_rep4.raw	EGF	enrichment of phosphorylated Protein
Sample 26	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	1	cell	run 96	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120415_EXQ5_KiSh_SA_LabelFree_HeLa_pY_Noco_rep1.raw	20120415_EXQ5_KiSh_SA_LabelFree_HeLa_pY_Noco_rep1.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 27	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	2	cell	run 97	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120415_EXQ5_KiSh_SA_LabelFree_HeLa_pY_Noco_rep2.raw	20120415_EXQ5_KiSh_SA_LabelFree_HeLa_pY_Noco_rep2.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 28	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	3	cell	run 98	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120415_EXQ5_KiSh_SA_LabelFree_HeLa_pY_Noco_rep3.raw	20120415_EXQ5_KiSh_SA_LabelFree_HeLa_pY_Noco_rep3.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 29	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	enrichment of phosphorylated Protein	4	cell	run 99	proteomic profiling by mass spectrometry	NT=Strong cation-exchange chromatography (SCX);AC=PRIDE:0000561	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120415_EXQ5_KiSh_SA_LabelFree_HeLa_pY_Noco_rep4.raw	20120415_EXQ5_KiSh_SA_LabelFree_HeLa_pY_Noco_rep4.raw	Nocodazole	enrichment of phosphorylated Protein
Sample 30	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	1	cell	run 100	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep1_pH11.raw	20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep1_pH11.raw	none	no enrichment
Sample 30	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	1	cell	run 101	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep1_pH3.raw	20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep1_pH3.raw	none	no enrichment
Sample 30	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	1	cell	run 102	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep1_pH4.raw	20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep1_pH4.raw	none	no enrichment
Sample 30	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	1	cell	run 103	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep1_pH5.raw	20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep1_pH5.raw	none	no enrichment
Sample 30	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	1	cell	run 104	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep1_pH6.raw	20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep1_pH6.raw	none	no enrichment
Sample 30	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	1	cell	run 105	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep1_pH8.raw	20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep1_pH8.raw	none	no enrichment
Sample 31	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	2	cell	run 106	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep2_pH11.raw	20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep2_pH11.raw	none	no enrichment
Sample 31	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	2	cell	run 107	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep2_pH3.raw	20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep2_pH3.raw	none	no enrichment
Sample 31	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	2	cell	run 108	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep2_pH4.raw	20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep2_pH4.raw	none	no enrichment
Sample 31	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	2	cell	run 109	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep2_pH5.raw	20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep2_pH5.raw	none	no enrichment
Sample 31	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	2	cell	run 110	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep2_pH6.raw	20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep2_pH6.raw	none	no enrichment
Sample 31	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	2	cell	run 111	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep2_pH8.raw	20111219_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep2_pH8.raw	none	no enrichment
Sample 32	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	3	cell	run 112	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111222_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep3_pH11.raw	20111222_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep3_pH11.raw	none	no enrichment
Sample 32	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	3	cell	run 113	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111222_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep3_pH3.raw	20111222_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep3_pH3.raw	none	no enrichment
Sample 32	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	3	cell	run 114	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111222_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep3_pH4.raw	20111222_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep3_pH4.raw	none	no enrichment
Sample 32	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	3	cell	run 115	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111222_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep3_pH5.raw	20111222_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep3_pH5.raw	none	no enrichment
Sample 32	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	3	cell	run 116	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111222_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep3_pH6.raw	20111222_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep3_pH6.raw	none	no enrichment
Sample 32	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	3	cell	run 117	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111222_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep3_pH8.raw	20111222_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep3_pH8.raw	none	no enrichment
Sample 33	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	4	cell	run 118	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH11.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH11.raw	none	no enrichment
Sample 33	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	4	cell	run 119	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH3.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH3.raw	none	no enrichment
Sample 33	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	4	cell	run 120	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH4.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH4.raw	none	no enrichment
Sample 33	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	4	cell	run 121	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH5.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH5.raw	none	no enrichment
Sample 33	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	4	cell	run 122	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH6.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH6.raw	none	no enrichment
Sample 33	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	4	cell	run 123	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH8.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH8.raw	none	no enrichment
Sample 34	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	5	cell	run 124	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH11.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH11.raw	none	no enrichment
Sample 34	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	5	cell	run 125	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH3.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH3.raw	none	no enrichment
Sample 34	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	5	cell	run 126	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH4.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH4.raw	none	no enrichment
Sample 34	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	5	cell	run 127	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH5.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH5.raw	none	no enrichment
Sample 34	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	5	cell	run 128	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH6.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH6.raw	none	no enrichment
Sample 34	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	5	cell	run 129	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH8.raw	20111225_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH8.raw	none	no enrichment
Sample 35	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	6	cell	run 130	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120125_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH11.raw	20120125_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH11.raw	none	no enrichment
Sample 35	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	6	cell	run 131	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120125_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH3.raw	20120125_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH3.raw	none	no enrichment
Sample 35	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	6	cell	run 132	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120125_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH4.raw	20120125_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH4.raw	none	no enrichment
Sample 35	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	6	cell	run 133	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120125_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH5.raw	20120125_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH5.raw	none	no enrichment
Sample 35	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	6	cell	run 134	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120125_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH6.raw	20120125_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH6.raw	none	no enrichment
Sample 35	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	6	cell	run 135	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120125_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH8.raw	20120125_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH8.raw	none	no enrichment
Sample 36	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	1	cell	run 136	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120203_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH11.raw	20120203_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH11.raw	Nocodazole	no enrichment
Sample 36	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	1	cell	run 137	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120203_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH3.raw	20120203_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH3.raw	Nocodazole	no enrichment
Sample 36	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	1	cell	run 138	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120203_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH4.raw	20120203_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH4.raw	Nocodazole	no enrichment
Sample 36	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	1	cell	run 139	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120203_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH5.raw	20120203_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH5.raw	Nocodazole	no enrichment
Sample 36	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	1	cell	run 140	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120203_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH6.raw	20120203_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH6.raw	Nocodazole	no enrichment
Sample 36	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	1	cell	run 141	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120203_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH8.raw	20120203_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH8.raw	Nocodazole	no enrichment
Sample 37	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	2	cell	run 142	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120204_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH11.raw	20120204_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH11.raw	Nocodazole	no enrichment
Sample 37	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	2	cell	run 143	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120204_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH3.raw	20120204_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH3.raw	Nocodazole	no enrichment
Sample 37	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	2	cell	run 144	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120204_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH4.raw	20120204_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH4.raw	Nocodazole	no enrichment
Sample 37	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	2	cell	run 145	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120204_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH5.raw	20120204_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH5.raw	Nocodazole	no enrichment
Sample 37	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	2	cell	run 146	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120204_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH6.raw	20120204_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH6.raw	Nocodazole	no enrichment
Sample 37	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	2	cell	run 147	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120204_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH8.raw	20120204_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH8.raw	Nocodazole	no enrichment
Sample 38	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	3	cell	run 148	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120218_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH11.raw	20120218_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH11.raw	Nocodazole	no enrichment
Sample 38	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	3	cell	run 149	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120218_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH3.raw	20120218_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH3.raw	Nocodazole	no enrichment
Sample 38	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	3	cell	run 150	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120218_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH4.raw	20120218_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH4.raw	Nocodazole	no enrichment
Sample 38	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	3	cell	run 151	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120218_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH5.raw	20120218_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH5.raw	Nocodazole	no enrichment
Sample 38	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	3	cell	run 152	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120218_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH6.raw	20120218_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH6.raw	Nocodazole	no enrichment
Sample 38	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	3	cell	run 153	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120218_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH8.raw	20120218_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH8.raw	Nocodazole	no enrichment
Sample 39	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	4	cell	run 154	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120220_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH11.raw	20120220_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH11.raw	Nocodazole	no enrichment
Sample 39	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	4	cell	run 155	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120220_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH3.raw	20120220_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH3.raw	Nocodazole	no enrichment
Sample 39	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	4	cell	run 156	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120220_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH4.raw	20120220_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH4.raw	Nocodazole	no enrichment
Sample 39	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	4	cell	run 157	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120220_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH5.raw	20120220_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH5.raw	Nocodazole	no enrichment
Sample 39	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	4	cell	run 158	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120220_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH6.raw	20120220_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH6.raw	Nocodazole	no enrichment
Sample 39	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	4	cell	run 159	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120220_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH8.raw	20120220_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH8.raw	Nocodazole	no enrichment
Sample 40	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	1	cell	run 160	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH11.raw	20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH11.raw	EGF	no enrichment
Sample 40	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	1	cell	run 161	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH3.raw	20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH3.raw	EGF	no enrichment
Sample 40	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	1	cell	run 162	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH4.raw	20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH4.raw	EGF	no enrichment
Sample 40	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	1	cell	run 163	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH5.raw	20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH5.raw	EGF	no enrichment
Sample 40	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	1	cell	run 164	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH6.raw	20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH6.raw	EGF	no enrichment
Sample 40	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	1	cell	run 165	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH8.raw	20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH8.raw	EGF	no enrichment
Sample 41	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	2	cell	run 166	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH11.raw	20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH11.raw	EGF	no enrichment
Sample 41	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	2	cell	run 167	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH3.raw	20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH3.raw	EGF	no enrichment
Sample 41	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	2	cell	run 168	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH4.raw	20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH4.raw	EGF	no enrichment
Sample 41	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	2	cell	run 169	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH5.raw	20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH5.raw	EGF	no enrichment
Sample 41	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	2	cell	run 170	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH6.raw	20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH6.raw	EGF	no enrichment
Sample 41	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	2	cell	run 171	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH8.raw	20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH8.raw	EGF	no enrichment
Sample 42	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	3	cell	run 172	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH11.raw	20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH11.raw	EGF	no enrichment
Sample 42	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	3	cell	run 173	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH3.raw	20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH3.raw	EGF	no enrichment
Sample 42	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	3	cell	run 174	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH4.raw	20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH4.raw	EGF	no enrichment
Sample 42	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	3	cell	run 175	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH5.raw	20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH5.raw	EGF	no enrichment
Sample 42	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	3	cell	run 176	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH6.raw	20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH6.raw	EGF	no enrichment
Sample 42	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	3	cell	run 177	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH8.raw	20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH8.raw	EGF	no enrichment
Sample 43	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	4	cell	run 178	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH11.raw	20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH11.raw	EGF	no enrichment
Sample 43	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	4	cell	run 179	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH3.raw	20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH3.raw	EGF	no enrichment
Sample 43	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	4	cell	run 180	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH4.raw	20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH4.raw	EGF	no enrichment
Sample 43	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	4	cell	run 181	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH5.raw	20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH5.raw	EGF	no enrichment
Sample 43	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	4	cell	run 182	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH6.raw	20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH6.raw	EGF	no enrichment
Sample 43	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	4	cell	run 183	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH8.raw	20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH8.raw	EGF	no enrichment
Sample 44	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	1	cell	run 184	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH11.raw	20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH11.raw	EGF	no enrichment
Sample 44	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	1	cell	run 185	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH3.raw	20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH3.raw	EGF	no enrichment
Sample 44	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	1	cell	run 186	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH4.raw	20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH4.raw	EGF	no enrichment
Sample 44	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	1	cell	run 187	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH5.raw	20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH5.raw	EGF	no enrichment
Sample 44	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	1	cell	run 188	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH6.raw	20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH6.raw	EGF	no enrichment
Sample 44	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	1	cell	run 189	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH8.raw	20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH8.raw	EGF	no enrichment
Sample 45	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	2	cell	run 190	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH11.raw	20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH11.raw	EGF	no enrichment
Sample 45	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	2	cell	run 191	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH3.raw	20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH3.raw	EGF	no enrichment
Sample 45	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	2	cell	run 192	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH4.raw	20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH4.raw	EGF	no enrichment
Sample 45	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	2	cell	run 193	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH5.raw	20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH5.raw	EGF	no enrichment
Sample 45	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	2	cell	run 194	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH6.raw	20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH6.raw	EGF	no enrichment
Sample 45	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	2	cell	run 195	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH8.raw	20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH8.raw	EGF	no enrichment
Sample 46	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	3	cell	run 196	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH11.raw	20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH11.raw	EGF	no enrichment
Sample 46	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	3	cell	run 197	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH3.raw	20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH3.raw	EGF	no enrichment
Sample 46	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	3	cell	run 198	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH4.raw	20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH4.raw	EGF	no enrichment
Sample 46	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	3	cell	run 199	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH5.raw	20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH5.raw	EGF	no enrichment
Sample 46	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	3	cell	run 200	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH6.raw	20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH6.raw	EGF	no enrichment
Sample 46	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	3	cell	run 201	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH8.raw	20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH8.raw	EGF	no enrichment
Sample 47	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	4	cell	run 202	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH11.raw	20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH11.raw	EGF	no enrichment
Sample 47	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	4	cell	run 203	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH3.raw	20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH3.raw	EGF	no enrichment
Sample 47	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	4	cell	run 204	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH4.raw	20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH4.raw	EGF	no enrichment
Sample 47	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	4	cell	run 205	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH5.raw	20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH5.raw	EGF	no enrichment
Sample 47	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	4	cell	run 206	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH6.raw	20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH6.raw	EGF	no enrichment
Sample 47	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	4	cell	run 207	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH8.raw	20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH8.raw	EGF	no enrichment
Sample 48	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	1	cell	run 208	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120329_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep1_pH11.raw	20120329_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep1_pH11.raw	pervandate	no enrichment
Sample 48	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	1	cell	run 209	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120329_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep1_pH3.raw	20120329_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep1_pH3.raw	pervandate	no enrichment
Sample 48	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	1	cell	run 210	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120329_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep1_pH4.raw	20120329_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep1_pH4.raw	pervandate	no enrichment
Sample 48	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	1	cell	run 211	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120329_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep1_pH5.raw	20120329_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep1_pH5.raw	pervandate	no enrichment
Sample 48	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	1	cell	run 212	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120329_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep1_pH6.raw	20120329_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep1_pH6.raw	pervandate	no enrichment
Sample 48	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	1	cell	run 213	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120329_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep1_pH8.raw	20120329_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep1_pH8.raw	pervandate	no enrichment
Sample 49	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	2	cell	run 214	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120330_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep2_pH11.raw	20120330_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep2_pH11.raw	pervandate	no enrichment
Sample 49	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	2	cell	run 215	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120330_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep2_pH3.raw	20120330_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep2_pH3.raw	pervandate	no enrichment
Sample 49	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	2	cell	run 216	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120330_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep2_pH4.raw	20120330_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep2_pH4.raw	pervandate	no enrichment
Sample 49	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	2	cell	run 217	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120330_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep2_pH5.raw	20120330_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep2_pH5.raw	pervandate	no enrichment
Sample 49	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	2	cell	run 218	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120330_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep2_pH6.raw	20120330_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep2_pH6.raw	pervandate	no enrichment
Sample 49	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	2	cell	run 219	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120330_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep2_pH8.raw	20120330_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep2_pH8.raw	pervandate	no enrichment
Sample 50	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	3	cell	run 220	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120401_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep3_pH11.raw	20120401_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep3_pH11.raw	pervandate	no enrichment
Sample 50	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	3	cell	run 221	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120401_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep3_pH3.raw	20120401_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep3_pH3.raw	pervandate	no enrichment
Sample 50	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	3	cell	run 222	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120401_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep3_pH4.raw	20120401_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep3_pH4.raw	pervandate	no enrichment
Sample 50	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	3	cell	run 223	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120401_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep3_pH5.raw	20120401_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep3_pH5.raw	pervandate	no enrichment
Sample 50	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	3	cell	run 224	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120401_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep3_pH6.raw	20120401_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep3_pH6.raw	pervandate	no enrichment
Sample 50	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	3	cell	run 225	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120401_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep3_pH8.raw	20120401_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep3_pH8.raw	pervandate	no enrichment
Sample 51	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	4	cell	run 226	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120402_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep4_pH11.raw	20120402_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep4_pH11.raw	pervandate	no enrichment
Sample 51	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	4	cell	run 227	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120402_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep4_pH3.raw	20120402_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep4_pH3.raw	pervandate	no enrichment
Sample 51	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	4	cell	run 228	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120402_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep4_pH4.raw	20120402_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep4_pH4.raw	pervandate	no enrichment
Sample 51	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	4	cell	run 229	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120402_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep4_pH5.raw	20120402_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep4_pH5.raw	pervandate	no enrichment
Sample 51	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	4	cell	run 230	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120402_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep4_pH6.raw	20120402_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep4_pH6.raw	pervandate	no enrichment
Sample 51	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug pervandate	epithelial cell	HeLa-S3	no enrichment	4	cell	run 231	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120402_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep4_pH8.raw	20120402_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_PV_rep4_pH8.raw	pervandate	no enrichment
Sample 52	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	4	cell	run 232	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH11.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH11.raw	none	no enrichment
Sample 52	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	4	cell	run 233	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH3.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH3.raw	none	no enrichment
Sample 52	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	4	cell	run 234	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH4.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH4.raw	none	no enrichment
Sample 52	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	4	cell	run 235	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH5.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH5.raw	none	no enrichment
Sample 52	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	4	cell	run 236	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH6.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH6.raw	none	no enrichment
Sample 52	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	4	cell	run 237	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH8.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep4_pH8.raw	none	no enrichment
Sample 53	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	5	cell	run 238	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH11.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH11.raw	none	no enrichment
Sample 53	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	5	cell	run 239	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH3.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH3.raw	none	no enrichment
Sample 53	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	5	cell	run 240	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH4.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH4.raw	none	no enrichment
Sample 53	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	5	cell	run 241	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH5.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH5.raw	none	no enrichment
Sample 53	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	5	cell	run 242	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH6.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH6.raw	none	no enrichment
Sample 53	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	5	cell	run 243	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH8.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep5_pH8.raw	none	no enrichment
Sample 54	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	6	cell	run 244	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH11.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH11.raw	none	no enrichment
Sample 54	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	6	cell	run 245	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH3.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH3.raw	none	no enrichment
Sample 54	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	6	cell	run 246	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH4.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH4.raw	none	no enrichment
Sample 54	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	6	cell	run 247	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH5.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH5.raw	none	no enrichment
Sample 54	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	6	cell	run 248	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH6.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH6.raw	none	no enrichment
Sample 54	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: none	epithelial cell	HeLa-S3	no enrichment	6	cell	run 249	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH8.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Control_rep6_pH8.raw	none	no enrichment
Sample 55	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	1	cell	run 250	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH11.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH11.raw	Nocodazole	no enrichment
Sample 55	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	1	cell	run 251	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH3.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH3.raw	Nocodazole	no enrichment
Sample 55	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	1	cell	run 252	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH4.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH4.raw	Nocodazole	no enrichment
Sample 55	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	1	cell	run 253	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH5.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH5.raw	Nocodazole	no enrichment
Sample 55	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	1	cell	run 254	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH6.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH6.raw	Nocodazole	no enrichment
Sample 55	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	1	cell	run 255	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH8.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep1_pH8.raw	Nocodazole	no enrichment
Sample 56	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	2	cell	run 256	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH11.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH11.raw	Nocodazole	no enrichment
Sample 56	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	2	cell	run 257	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH3.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH3.raw	Nocodazole	no enrichment
Sample 56	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	2	cell	run 258	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH4.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH4.raw	Nocodazole	no enrichment
Sample 56	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	2	cell	run 259	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH5.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH5.raw	Nocodazole	no enrichment
Sample 56	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	2	cell	run 260	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH6.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH6.raw	Nocodazole	no enrichment
Sample 56	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	2	cell	run 261	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH8.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep2_pH8.raw	Nocodazole	no enrichment
Sample 57	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	3	cell	run 262	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH11.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH11.raw	Nocodazole	no enrichment
Sample 57	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	3	cell	run 263	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH3.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH3.raw	Nocodazole	no enrichment
Sample 57	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	3	cell	run 264	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH4.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH4.raw	Nocodazole	no enrichment
Sample 57	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	3	cell	run 265	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH5.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH5.raw	Nocodazole	no enrichment
Sample 57	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	3	cell	run 266	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH6.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH6.raw	Nocodazole	no enrichment
Sample 57	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	3	cell	run 267	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH8.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep3_pH8.raw	Nocodazole	no enrichment
Sample 58	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	4	cell	run 268	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH11.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH11.raw	Nocodazole	no enrichment
Sample 58	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	4	cell	run 269	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH3.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH3.raw	Nocodazole	no enrichment
Sample 58	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	4	cell	run 270	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH4.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH4.raw	Nocodazole	no enrichment
Sample 58	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	4	cell	run 271	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH5.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH5.raw	Nocodazole	no enrichment
Sample 58	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	4	cell	run 272	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH6.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH6.raw	Nocodazole	no enrichment
Sample 58	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug Nocodazole	epithelial cell	HeLa-S3	no enrichment	4	cell	run 273	proteomic profiling by mass spectrometry	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH8.raw	pY_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_Nocodazole_rep4_pH8.raw	Nocodazole	no enrichment
